Preliminary results of a randomized phase II study of paclitaxel and bevacizumab ± gemcitabine as first-line treatment for metastatic breast cancer

被引：0
|
作者：
Hoelzer, K. L. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Brufsky, A. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Hainsworth, J. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Beck, J. T. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Whorf, R. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Keaton, M. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Kroener, J. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Krill-Jackson, E. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Hu, S. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Bromund, J. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
机构：
[1] Springfield Clin, Springfield, IL USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
[3] Sarah Cannon Res Inst, Nashville, TN USA
[4] Highlands Oncol Grp, Fayetteville, AR USA
[5] Florida Canc Specialists, Ft Myers, FL USA
[6] ACORN, Memphis, TN USA
[7] Scripps Clin, La Jolla, CA 92037 USA
[8] Mt Sinai Med Ctr, Miami, FL USA
[9] Lilly USA LLC, Indianapolis, IN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1089
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A Randomized Phase II Study of Paclitaxel and Bevacizumab With and Without Gemcitabine as First-Line Treatment for Metastatic Breast Cancer
    Brufsky, Adam
    Hoelzer, Karen
    Beck, Thaddeus
    Whorf, Robert
    Keaton, Mark
    Nadella, Padma
    Krill-Jackson, Elisa
    Kroener, Joan
    Middleman, Edward
    Frontiera, Michael
    Paul, Devchand
    Panella, Timothy
    Bromund, Jane
    Zhao, Luping
    Orlando, Mauro
    Tai, Fritz
    Marciniak, Martin D.
    Obasaju, Coleman
    Hainsworth, John
    [J]. CLINICAL BREAST CANCER, 2011, 11 (04) : 211 - 220
  • [2] A phase II study of paclitaxel and bevacizumab ± gemcitabine as first-line treatment for metastatic breast cancer (MBC): Interim safety results
    Brufsky, A. M.
    Hoelzer, K. L.
    Keaton, M. R.
    Beck, J. T.
    Krill-Jackson, E.
    Wang, Y.
    Hu, S.
    Vaughn, L. G.
    Shonukan, O. O.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] Preliminary results of a phase II study of epirubicin and paclitaxel as first-line treatment in patients with metastatic breast cancer
    Luck, HJ
    Thomssen, C
    duBois, A
    Lisboa, BW
    Untch, M
    Kuhnle, H
    Janicke, F
    Meerpohl, HG
    Lindner, C
    Kcnecny, G
    Hecker, D
    Diergarten, K
    [J]. SEMINARS IN ONCOLOGY, 1997, 24 (01) : S13 - S16
  • [4] Phase II Trial with Gemcitabine, Paclitaxel and Bevacizumab for the First Line Treatment of Metastatic Breast Cancer.
    Guardino, A. E.
    Chen, M.
    Levy, M.
    Chen, M.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 853S - 853S
  • [5] Final results of a phase II study of paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer
    Salvador, J.
    Manso, L.
    de la Haba, J.
    Jaen, A.
    Ciruelos, E.
    de Villena, M. C.
    Gil, M.
    Murias, A.
    Galan, A.
    Jara, C.
    Bayo, J.
    Baena, J. M.
    Casal, J.
    Mel, J. R.
    Blancas, I.
    Sanchez Rvira, P.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2015, 17 (02): : 160 - 166
  • [6] Final results of a phase II study of paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer
    J. Salvador
    L. Manso
    J. de la Haba
    A. Jaen
    E. Ciruelos
    M. C. de Villena
    M. Gil
    A. Murias
    A. Galan
    C. Jara
    J. Bayo
    J. M. Baena
    J. Casal
    J. R. Mel
    I. Blancas
    P. Sanchez Rvira
    [J]. Clinical and Translational Oncology, 2015, 17 : 160 - 166
  • [7] First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study
    Allouache, D
    Gawande, SR
    Tubiana-Hulin, M
    Tubiana-Mathieu, N
    Piperno-Neumann, S
    Mefti, F
    Bozec, L
    Genot, JY
    [J]. BMC CANCER, 2005, 5 (1)
  • [8] First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study
    Djelila Allouache
    Sulochana R Gawande
    Michele Tubiana-Hulin
    Nicole Tubiana-Mathieu
    Sophie Piperno-Neumann
    Fawzia Mefti
    Laurence Bozec
    Jean-Yves Genot
    [J]. BMC Cancer, 5
  • [9] Adding bevacizumab to paclitaxel in the first-line treatment of metastatic breast cancer
    Kevin R. Fox
    [J]. Current Oncology Reports, 2009, 11 : 5 - 7
  • [10] Adding Bevacizumab to Paclitaxel in the First-Line Treatment of Metastatic Breast Cancer
    Fox, Kevin R.
    [J]. CURRENT ONCOLOGY REPORTS, 2009, 11 (01) : 5 - 6
12345